Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Short term Debt: 2017-2023

Historic Short term Debt for BIO-TECHNE (TECH) over the last 6 years, with Jun 2023 value amounting to $3.5 million.

  • BIO-TECHNE's Short term Debt fell 76.35% to $1.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.8 million, marking a year-over-year decrease of 76.35%. This contributed to the annual value of $3.5 million for FY2023, which is 72.00% down from last year.
  • BIO-TECHNE's Short term Debt amounted to $3.5 million in FY2023, which was down 72.00% from $12.5 million recorded in FY2022.
  • BIO-TECHNE's 5-year Short term Debt high stood at $12.5 million for FY2019, and its period low was $3.5 million during FY2023.
  • Its 3-year average for Short term Debt is $9.5 million, with a median of $12.5 million in 2022.
  • Data for BIO-TECHNE's Short term Debt shows a maximum YoY crashed of 72.00% (in 2023) over the last 5 years.
  • Over the past 5 years, BIO-TECHNE's Short term Debt (Yearly) stood at $12.5 million in 2019, then remained steady at $12.5 million in 2020, then remained steady at $12.5 million in 2021, then remained steady at $12.5 million in 2022, then crashed by 72.00% to $3.5 million in 2023.